{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T15:27:40Z","timestamp":1764602860180},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1007\/s00246-008-9257-5","type":"journal-article","created":{"date-parts":[[2008,6,27]],"date-time":"2008-06-27T17:00:03Z","timestamp":1214586003000},"page":"1077-1081","source":"Crossref","is-referenced-by-count":9,"title":["Extemporaneous Suspension of Propafenone: Attending Lack of Pediatric Formulations in Mexico"],"prefix":"10.1007","volume":"29","author":[{"given":"Hugo","family":"Ju\u00e1rez Olgu\u00edn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Flores P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blanca","family":"Ram\u00edrez Mendiola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Coria Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eunice","family":"Sandoval Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janett","family":"Flores P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"9257_CR1","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00246-003-0692-z","volume":"25","author":"S Barnes","year":"2004","unstructured":"Barnes S, Shields B, Bonney W et\u00a0al (2004) The pediatric cardiology pharmacopoeia: 2004 update. Pediatr Cardiol 25:623\u2013646","journal-title":"Pediatr Cardiol"},{"key":"9257_CR2","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s002460010128","volume":"21","author":"MT Bink-Boelkens","year":"2000","unstructured":"Bink-Boelkens MT (2000) Pharmacologic management of arrhythmias. Pediatr Cardiol 21:508\u2013515","journal-title":"Pediatr Cardiol"},{"key":"9257_CR3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0167-5273(98)00363-5","volume":"68","author":"A Capucci","year":"1999","unstructured":"Capucci A, Villani GQ, Aschieri D et al (1999) Safety of oral propafenone in the conversion of recent-onset atrial fibrillation to sinus rhythm: a prospective parallel placebo-controlled multicentre study. Int J Cardiol 68:187\u2013196","journal-title":"Int J Cardiol"},{"key":"9257_CR4","first-page":"85","volume":"32","author":"A Celiker","year":"1992","unstructured":"Celiker A, Ozer S, Ozme S et\u00a0al (1992) Experience with propafenone for the treatment of cardiac arrhythmias in children. Turc J Pediatr 32:85\u201392","journal-title":"Turc J Pediatr"},{"key":"9257_CR5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1365\/s10337-005-0650-4","volume":"62","author":"C Flores P\u00e9rez","year":"2005","unstructured":"Flores P\u00e9rez C, Ju\u00e1rez Olgu\u00edn H, Flores P\u00e9rez J et\u00a0al (2005) A simple method to measure plasma levels of propafenone with fluorescence detection. Chromatographia 62:373\u2013377","journal-title":"Chromatographia"},{"key":"9257_CR6","first-page":"518","volume":"322","author":"C Funck-Brentano","year":"1995","unstructured":"Funck-Brentano C, Kroemer HK, Lee JT et al (1995) Propafenone. N Engl J Med 322:518\u2013525","journal-title":"N Engl J Med"},{"key":"9257_CR7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/clpt.1990.146","volume":"48","author":"EW Haefeli","year":"1990","unstructured":"Haefeli EW, Vozeh S, Ha HR et al (1990) Comparison of the pharmacodynamic effects of intravenous and oral propafenone. Clin Pharmacol Ther 48:245\u2013254","journal-title":"Clin Pharmacol Ther"},{"key":"9257_CR8","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0002-9149(98)00142-8","volume":"81","author":"J Janousek","year":"1998","unstructured":"Janousek J, Paul T (1998) Safety of oral propafenone in the treatment of arrhythmias in infants and children (European retrospective multicenter study). Working Group on Pediatric Arrhythmias and Electrophysiology of the Association of European Pediatric Cardiologists. Am J Cardiol 81:1121\u20131124","journal-title":"Am J Cardiol"},{"key":"9257_CR9","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/ajhp\/59.4.361","volume":"59","author":"CE Johnson","year":"2002","unstructured":"Johnson CE, Streetman DD (2002) Stability of oral suspensions of ursodiol made from tablets. Am J Health Syst Pharm 59:361\u2013363","journal-title":"Am J Health Syst Pharm"},{"key":"9257_CR10","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1093\/ajhp\/61.21.2311","volume":"61","author":"H Ju\u00e1rez Olgu\u00edn","year":"2004","unstructured":"Ju\u00e1rez Olgu\u00edn H, Flores P\u00e9rez J, Lares Asseff I et\u00a0al (2004) Medication related services in a Mexican pediatric hospital. Am J Health-Syst Pharm 61:2311\u20132312","journal-title":"Am J Health-Syst Pharm"},{"key":"9257_CR11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/bdd.505","volume":"27","author":"H Ju\u00e1rez Olgu\u00edn","year":"2006","unstructured":"Ju\u00e1rez Olgu\u00edn H, Flores P\u00e9rez C, Flores P\u00e9rez J et\u00a0al (2006) Bioavailability of an extemporaneous suspension of propafenone made from tablets. Biopharm Drug Dispos 27:241\u2013245","journal-title":"Biopharm Drug Dispos"},{"key":"9257_CR12","first-page":"138","volume":"14","author":"I Lares Asseff","year":"1993","unstructured":"Lares Asseff I, Ju\u00e1rez Olgu\u00edn H, Gomez-Zamarroni A et\u00a0al (1993) La unidad de farmacolog\u00eda cl\u00ednica: Un recurso para la ense\u00f1anza y la asistencia farmacol\u00f3gica. Acta Pediatr Mex 14:138\u2013143","journal-title":"Acta Pediatr Mex"},{"key":"9257_CR13","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2165\/00003088-200241080-00001","volume":"41","author":"R Mehvar","year":"2002","unstructured":"Mehvar R, Brocks DR, Vakily M (2002) Impact of stereoselectivity on the pharmacokinetics and pharmacodynamics of antiarrhythmic drugs. Clin Pharmacokinet 41:533\u2013558","journal-title":"Clin Pharmacokinet"},{"key":"9257_CR14","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1542\/peds.104.S3.607","volume":"104","author":"MC Nahata","year":"1999","unstructured":"Nahata MC (1999) Lack of pediatric drug formulations. Pediatrics 104:607\u2013609","journal-title":"Pediatrics"},{"key":"9257_CR15","unstructured":"Rodr\u00edguez P\u00e9rez R, Barrag\u00e1n Mej\u00eda MG, Castilla Serna L (1992) Paquest version 1.0 Biomedical Software Developed S. de R.L. de C.V., M\u00e9xico"},{"key":"9257_CR16","first-page":"687","volume-title":"Vad\u00e9mecum acad\u00e9mico de medicamentos","author":"R Rodr\u00edguiez","year":"2005","unstructured":"Rodr\u00edguiez R et\u00a0al (2005) Vad\u00e9mecum acad\u00e9mico de medicamentos, 4th edn. McGraw-Hill Interamericana, M\u00e9xico, D.F., pp 687\u2013688","edition":"4"},{"key":"9257_CR17","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0306-3623(98)00045-7","volume":"31","author":"S Sasaki","year":"1998","unstructured":"Sasaki S, Kuomi S, Sato R et\u00a0al (1998) Kinetics of buccal absorption of propafenone single oral loading dose in healthy humans. Gen Pharmacol 31:589\u2013591","journal-title":"Gen Pharmacol"},{"key":"9257_CR18","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1093\/ajhp\/56.22.2316","volume":"56","author":"HL VandenBussche","year":"1999","unstructured":"VandenBussche HL, Jonhson CE, Fontana EM et al (1999) Stability of levofloxasin in an extemporaneously compounded oral liquid. Am J Health Syst Pharm 56:2316\u20132318","journal-title":"Am J Health Syst Pharm"},{"key":"9257_CR19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00007691-199103000-00012","volume":"13","author":"R Verbesselt","year":"1991","unstructured":"Verbesselt R, Tjandramaga TB, de Schepper PJ (1991) High-performance liquid chromatographic determination of 12 antiarrhythmic drugs in plasma using solid-phase column extraction. Ther Drug Monit 13:157\u2013165","journal-title":"Ther Drug Monit"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-008-9257-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00246-008-9257-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-008-9257-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:39:10Z","timestamp":1684456750000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00246-008-9257-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,28]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["9257"],"URL":"https:\/\/doi.org\/10.1007\/s00246-008-9257-5","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"value":"0172-0643","type":"print"},{"value":"1432-1971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,28]]}}}